← The Wire
AUTLNasdaq
Autolus Therapeutics plc
Biological Products, (No Diagnostic Substances) · X0 · CIK 1730463
Developing, manufacturing, and delivering next-generation T cell therapies for cancer and autoimmune diseases
red 8-K · 90d
$415M
Market cap
$1.65
Last close
+2.5%
1D
+10.7%
5D
960K
Volume
Price · last 39 sessions+5.1%
May 4L $1.46 · H $1.87Jun 29
143
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 29, 20268-KCompany UpdateJun 9, 202610-Q10-QMay 14, 20268-KResults of Operations · Reg FD DisclosureMay 14, 20268-KExit / Disposal Costs · Reg FD DisclosureApr 29, 20268-KAuditor ChangeApr 16, 20268-KReg FD DisclosureApr 8, 202610-K10-KMar 27, 20268-KResults of Operations · Reg FD DisclosureMar 27, 20268-KMaterial AgreementJan 26, 20268-KReg FD Disclosure · Company UpdateJan 12, 20268-KExecutive Change · Reg FD DisclosureDec 2, 202510-Q10-QNov 12, 20258-KExecutive Change · Results of OperationsNov 12, 202510-Q10-QAug 12, 20258-KResults of Operations · Reg FD DisclosureAug 12, 20258-KShareholder VoteJun 27, 20258-KCompany UpdateJun 2, 20258-KExecutive ChangeMay 30, 2025S-1S-1May 8, 202510-Q10-QMay 8, 20258-KResults of Operations · Reg FD DisclosureMay 8, 20258-KReg FD DisclosureApr 23, 20258-KExecutive ChangeApr 3, 202510-K10-KMar 20, 20258-KResults of Operations · Reg FD DisclosureMar 20, 20258-KReg FD DisclosureJan 13, 202510-Q10-QNov 12, 2024SC 13GSC 13GNov 12, 20248-KResults of Operations · Reg FD DisclosureNov 12, 20248-KReg FD Disclosure · Company UpdateNov 12, 2024SC 13GSEC SCHEDULE 13GNov 8, 20248-KReg FD DisclosureSep 26, 20248-KCompany UpdateSep 19, 20248-KMaterial AgreementSep 13, 202410-Q10-QAug 8, 20248-KResults of Operations · Reg FD DisclosureAug 8, 20248-KShareholder VoteJun 28, 20248-KCompany UpdateJun 5, 20248-KReg FD DisclosureJun 3, 202410-Q10-QMay 17, 20248-KResults of Operations · Reg FD DisclosureMay 17, 20248-KReg FD DisclosureMay 13, 20248-KExecutive Change · Reg FD DisclosureApr 1, 202410-K10-KMar 21, 20248-KRestatementMar 21, 20248-K/AResults of OperationsMar 15, 20248-KResults of Operations · Reg FD DisclosureMar 14, 2024SC 13DSC 13DFeb 21, 20248-KReg FD DisclosureFeb 13, 2024424B5424B5Feb 9, 20248-KMaterial Agreement · Reg FD DisclosureFeb 8, 20248-KMaterial Agreement · Equity IssuanceFeb 8, 20248-KReg FD DisclosureJan 26, 20248-KExecutive Change · Reg FD DisclosureJan 10, 20248-KExecutive Change · Reg FD DisclosureDec 22, 20238-KReg FD DisclosureDec 11, 20238-KReg FD DisclosureNov 27, 202310-Q10-QNov 9, 20238-KReg FD DisclosureNov 9, 20236-K6-KNov 2, 20236-K6-KAug 3, 20236-K6-KJul 21, 2023SC 13GSC 13GJul 10, 20236-K6-KJul 6, 20236-K6-KJun 20, 20236-K6-KJun 6, 20236-K6-KJun 6, 20236-K6-KMay 4, 2023SC 13GTETRAGON FINANCIAL MANAGEMENT LPMar 20, 20236-K6-KMar 14, 202320-F20-FMar 7, 2023SC 13GSC 13GFeb 14, 20236-K6-KJan 23, 20236-K6-KDec 21, 2022SC 13GSC 13GDec 19, 2022SC 13GACQUISITION OF BENEFICIAL OWNERSHIPDec 13, 20226-K6-KDec 12, 2022424B5424B5Dec 12, 20226-K6-KDec 8, 2022
Similar companies
Comparable business profile · signals at a glance